iXOS® (Xylooligosaccharides Prebiotic)

Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

iXOS® (Compound Solutions) is a patented xylooligosaccharide (XOS) prebiotic fiber derived from non-GMO corn cobs — providing one of the most selective and effective prebiotic fibers for feeding Bifidobacterium and Lactobacillus species in the gut microbiome. XOS requires remarkably low doses (1–2g/day) to achieve significant bifidogenic effects — 2–5x lower than FOS, GOS, or inulin — making it ideal for inclusion in capsule-format supplements, functional foods, and protein powders without bulking the serving size.

Studied Dose 1–2g/day iXOS® for prebiotic bifidogenic effects (much lower than other prebiotics at 5–15g/day); effective at just 1g/day in clinical studies
Active Compound Xylooligosaccharides (XOS, degree of polymerization 2–10) — iXOS® by Compound Solutions; non-GMO corn cob derived; standardized for xylobiose and xylotriose content

Benefits

Highly selective bifidogenic prebiotic at low dose

iXOS® (XOS) preferentially feeds Bifidobacterium species — beneficial bacteria associated with immune function, metabolic health, and reduced gut inflammation — at doses as low as 1g/day. This selectivity for beneficial bacteria over pathogenic species, at a dose 5–10x lower than inulin or FOS, makes iXOS® the most formulator-friendly prebiotic for inclusion in capsules and functional foods.

Gut microbiome diversity and health

Multiple clinical studies confirm XOS supplementation significantly increases Bifidobacterium counts, improves microbiome diversity, reduces pathogenic bacteria ratios, and improves gut transit time. These microbiome improvements translate to better immune function, reduced systemic inflammation, improved metabolic markers, and enhanced short-chain fatty acid (SCFA) production.

Metabolic and immune health benefits

XOS fermentation by gut bacteria produces butyrate, propionate, and acetate — short-chain fatty acids (SCFAs) that feed colonocytes, regulate immune T-cell differentiation, and improve insulin sensitivity. Clinical studies link XOS supplementation to improved blood glucose, reduced LDL cholesterol, and enhanced mucosal immune defense.

Mechanism of action

1

Selective Bifidobacterium fermentation and SCFA production

XOS passes undigested to the colon where Bifidobacterium species — possessing specific beta-xylosidase enzymes — selectively ferment it as a preferred substrate. This selective fermentation increases Bifidobacterium abundance and produces butyrate (colonocyte fuel, anti-inflammatory, histone deacetylase inhibitor), propionate (hepatic gluconeogenesis inhibitor, satiety signal), and acetate — SCFAs with systemic metabolic and immune benefits.

Clinical trials

1
XOS for Bifidobacterium and Microbiome — RCT
PubMed

Randomized, double-blind, placebo-controlled trial of xylooligosaccharides (XOS, 1-2.8 g/day) effects on gut microbiome composition, Bifidobacterium counts, and metabolic markers in healthy adults. (Lecerf et al. 2012, Br J Nutr — or related early XOS RCTs)

Healthy adults.

XOS at 1 g/day significantly increased Bifidobacterium counts and improved microbiome diversity. Modest reductions in fasting blood glucose. Note: XOS is unusually low-dose for a prebiotic — most prebiotics (inulin, GOS) require 5-10+ g/day for similar effects. The low effective dose makes XOS practical for inclusion in functional foods without meaningful FODMAP load.

Side effects and drug interactions

Common Potential side effects

Excellent GI tolerance at 1–2g/day — significantly better than FOS or inulin
Mild bloating at higher doses (>5g/day)
Corn-derived — relevant for corn allergy (rare); non-GMO

Important Drug interactions

No established drug interactions at prebiotic doses
Immunosuppressants — microbiome changes could theoretically affect drug metabolism; no clinical concern established

Frequently asked questions about iXOS® (Xylooligosaccharides Prebiotic)

What is iXOS® (Xylooligosaccharides Prebiotic)?

iXOS® (Compound Solutions) is a patented xylooligosaccharide (XOS) prebiotic fiber derived from non-GMO corn cobs — providing one of the most selective and effective prebiotic fibers for feeding Bifidobacterium and Lactobacillus species in the gut microbiome.

What does iXOS® (Xylooligosaccharides Prebiotic) do?

XOS passes undigested to the colon where Bifidobacterium species — possessing specific beta-xylosidase enzymes — selectively ferment it as a preferred substrate. In clinical research, iXOS® (Xylooligosaccharides Prebiotic) has been studied for highly selective bifidogenic prebiotic at low dose, gut microbiome diversity and health, metabolic and immune health benefits.

Who should take iXOS® (Xylooligosaccharides Prebiotic)?

iXOS® (Xylooligosaccharides Prebiotic) may be most relevant for people interested in immune support, metabolic health, gut health. It has been clinically studied for highly selective bifidogenic prebiotic at low dose, gut microbiome diversity and health, metabolic and immune health benefits. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does iXOS® (Xylooligosaccharides Prebiotic) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take iXOS® (Xylooligosaccharides Prebiotic)?

For immune support, iXOS® (Xylooligosaccharides Prebiotic) can typically be taken in the morning with breakfast. For acute illness use, follow product labeling — dosing frequency and timing may differ from preventive use. Always check product labeling and follow personalized guidance from your healthcare provider.

Is iXOS® (Xylooligosaccharides Prebiotic) worth taking?

iXOS® (Xylooligosaccharides Prebiotic) has moderate clinical evidence (Evidence Level 3/5 on NutraSmarts) — meaningful trial support exists, though results are less consistent than top-tier ingredients. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. iXOS® (Xylooligosaccharides Prebiotic) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of iXOS® (Xylooligosaccharides Prebiotic)?

The clinically studied dose for iXOS® (Xylooligosaccharides Prebiotic) is 1–2g/day iXOS® for prebiotic bifidogenic effects (much lower than other prebiotics at 5–15g/day); effective at just 1g/day in clinical studies. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is iXOS® (Xylooligosaccharides Prebiotic) used for?

iXOS® (Xylooligosaccharides Prebiotic) is studied for highly selective bifidogenic prebiotic at low dose, gut microbiome diversity and health, metabolic and immune health benefits. iXOS® (XOS) preferentially feeds Bifidobacterium species — beneficial bacteria associated with immune function, metabolic health, and reduced gut inflammation — at doses as low as 1g/day.